Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors

Alina Nicoara1, David Ruffin1, Mary Cooter1

  • 1Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA.

Insights

Primary graft dysfunction (PGD) after heart transplantation (HT) affects 31% of patients. Key risk factors include longer ischemic times and specific recipient characteristics, highlighting the need for targeted interventions to improve outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Heart transplantation (HT) is a life-saving procedure, but primary graft dysfunction (PGD) remains a significant complication.
  • Donor and recipient demographics are evolving, potentially impacting PGD incidence.

Purpose of the Study:

  • To evaluate the incidence, trends, and risk factors associated with PGD in adult heart transplant recipients.
  • To identify specific demographic and clinical variables linked to PGD development.

Main Methods:

  • Retrospective analysis of 317 adult patients undergoing HT between January 2009 and December 2014.
  • Utilized International Society for Heart & Lung Transplantation (ISHLT) criteria for PGD categorization.
  • Assessed clinical and demographic factors for independent association with PGD, including time-trend analysis.

Main Results:

  • PGD occurred in 31% of patients (99/317).
  • Independent risk factors for PGD included prolonged ischemic time, African American race, and pretransplantation amiodarone use.
  • No significant change in PGD incidence over the study period, but increased amiodarone use was noted.
  • 30-day mortality was significantly higher in patients with PGD (6.06% vs. 0.92%).

Conclusions:

  • PGD incidence remains high despite advancements in heart transplantation.
  • Identifying and understanding risk factors like ischemic time and recipient characteristics is crucial for developing targeted interventions.
  • Further research is needed to mitigate PGD and improve post-transplant outcomes.